JAZZ Jazz Pharmaceuticals plc
Price Chart
Executive Summary
Three Jazz Pharmaceuticals insiders sold a total of $3.32M in open-market transactions over a 7-day window, including the Chief Commercial Officer and a Director. The sales are modest relative to the $14.2B market cap (~0.02%) and are partially offset by derivative exercises at lower strike prices, suggesting routine portfolio rebalancing rather than a bearish signal.
Key Financial Metrics
Actionable Insight
The cluster is routine in size and composition — no material signal for traders. The derivative-exercise-linked sales suggest tax/vesting mechanics, not informed selling. Monitor the next 8-K or earnings release for any fundamental changes, but this filing alone does not warrant a position adjustment.
Key Facts
- Total insider sales: $3.32M across 3 insiders (Director, EVP Chief Commercial Officer, EVP Chief Legal Officer)
- Sales represent ~0.02% of Jazz's $14.2B market cap — well below the 0.1% materiality threshold
- Two of the three sales (Pearce and Mulligan) were paired with derivative exercises at $109.45 and $138.08, indicating tax-covering or cashless exercise patterns
- No insider purchases were reported in the cluster window
- Prior 30-day insider activity: 5 sells totaling $4.5M, consistent with ongoing routine selling
Financial Impact
Total insider sales of $3.32M represent 0.02% of market cap — immaterial
Risk Factors
- Insider selling could accelerate if management sees headwinds from Xywav/Xyrem patent cliffs or pipeline delays
- Historical calibration shows JAZZ insider cluster reports have low predictive power (33% win rate at T+20)
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-JAZZ-1780521015525 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
6d ago
|
DEFA14A
| $231.98 awaiting T+1 | awaiting T+1 | — | $230.56 (−0.61%) |
|
Jun 3, 2026
11d ago
|
Insider Cluster
| $239.17 $238.57 | ▲ +0.25% | ▼ −2.32% | $230.56 (+3.60%) |
|
Jun 3, 2026
11d ago
|
Insider Cluster
| $240.06 $238.57 | ▼ −0.62% | ▲ +1.98% | $230.56 (−3.96%) |
|
Jun 1, 2026
13d ago
|
144
| $226.12 $230.93 | ▲ +2.13% | ▲ +2.85% | $230.56 (+1.96%) |
|
May 29, 2026
16d ago
|
8-K
| $231.19 $226.12 | ▼ −2.19% | ▼ −2.34% | $230.56 (−0.27%) |
|
May 1, 2026
6w ago
|
144
| $202.51 $207.89 | ▲ +2.66% | ▲ +3.00% | $230.56 (+13.85%) |
|
Apr 24, 2026
7w ago
|
10-K/A
| $200.31 $203.07 | ▲ +1.38% | ▲ +1.86% | $230.56 (+15.10%) |
|
Apr 1, 2026
10w ago
|
144
| $186.73 $185.83 | ▼ −0.48% | ▼ −0.96% | $230.56 (+23.47%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $230.56 (+21.99%) |
|
Feb 27, 2026
15w ago
|
Insider Cluster
| $189.00 $190.30 | ▲ +0.69% | ▲ +0.63% | $230.56 (+21.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access